Advanced Glycation End Products Subspecies-Selectively Induce Adhesion Molecule Expression and Cytokine Production in Human Peripheral Blood Mononuclear Cells-Reference-Cited by-同舟云学术

Advanced Glycation End Products Subspecies-Selectively Induce Adhesion Molecule Expression and Cytokine Production in Human Peripheral Blood Mononuclear Cells

Published:2009-04-20 Issue:1 Volume:330 Page:89-98
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Takahashi Hideo Kohka,Mori Shuji,Wake Hidenori,Liu Keyue,Yoshino Tadashi,Ohashi Katsuhisa,Tanaka Noriaki,Shikata Kenichi,Makino Hirofumi,Nishibori Masahiro

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference39 articles.

1. Macrophage Activation in Atherosclerosis: Pathogenesis and Pharmacology of Plaque Rupture

2. Human Blood-Derived Macrophages Induce Apoptosis in Human Plaque-Derived Vascular Smooth Muscle Cells by Fas-Ligand/Fas Interactions

3. Tumor Necrosis Factor-α Promotes Macrophage-Induced Vascular Smooth Muscle Cell Apoptosis by Direct and Autocrine Mechanisms

4. ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING

5. Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of inflammatory signaling pathways involving the CD40–CD40L–TRAF cascade in diabetes and hypertension—insights from animal and human studies;Basic Research in Cardiology;2024-03-30

2. Advanced Glycation End Products Upregulate CD40 in Human Retinal Endothelial and Müller Cells: Relevance to Diabetic Retinopathy;Cells;2024-02-29

3. Glycolaldehyde-derived advanced glycation end products suppress STING/TBK1/IRF3 signaling via CD36;Life Sciences;2022-12

4. Diabetes and Impaired Fracture Healing: A Narrative Review of Recent Literature;Current Osteoporosis Reports;2022-08-12

5. Cardiovascular Protection Associated With Cilostazol, Colchicine, and Target of Rapamycin Inhibitors;Journal of Cardiovascular Pharmacology;2022-07